Literature DB >> 12956606

A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders.

Vladimir N Uversky1.   

Abstract

Under the physiological conditions in vitro, alpha-synuclein, a conservative presynaptic protein, the aggregation and fibrillation of which is assumed to be involved into the pathogenesis of Parkinson's disease and several other neurodegenerative disorders, known as synucleinopathies, is characterized by the lack of rigid well-defined structure; i.e., it belongs to the class of intrinsically unstructured proteins. Intriguingly, alpha-synuclein is characterized by a remarkable conformational plasticity, adopting a series of different conformations depending on the environment. For example, this protein may either stay substantially unfolded, or adopt an amyloidogenic partially folded conformation, or fold into alpha-helical or beta-structural species, both monomeric and oligomeric. Furthermore, it might form several morphologically different types of aggregates, including oligomers (spheres or doughnuts), amorphous aggregates, and or amyloid-like fibrils. The peculiarities of this astonishing conformational behavior are analyzed to shed light on structural plasticity of this protein-chameleon.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956606     DOI: 10.1080/07391102.2003.10506918

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  136 in total

Review 1.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Evolution of structurally disordered proteins promotes neostructuralization.

Authors:  Jessica Siltberg-Liberles
Journal:  Mol Biol Evol       Date:  2010-10-29       Impact factor: 16.240

3.  p25alpha is flexible but natively folded and binds tubulin with oligomeric stoichiometry.

Authors:  Daniel E Otzen; Ditte M S Lundvig; Reinhard Wimmer; Lotte H Nielsen; Jakob R Pedersen; Poul H Jensen
Journal:  Protein Sci       Date:  2005-05-09       Impact factor: 6.725

Review 4.  Nanoimaging for protein misfolding and related diseases.

Authors:  Yuri L Lyubchenko; Simon Sherman; Luda S Shlyakhtenko; Vladimir N Uversky
Journal:  J Cell Biochem       Date:  2006-09-01       Impact factor: 4.429

5.  Amyloid formation in denatured single-mutant lysozymes where residual structures are modulated.

Authors:  Tomonori Mishima; Takatoshi Ohkuri; Akira Monji; Taiji Imoto; Tadashi Ueda
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

Review 6.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

7.  Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

8.  Concerted action of metals and macromolecular crowding on the fibrillation of alpha-synuclein.

Authors:  Larissa A Munishkina; Anthony L Fink; Vladimir N Uversky
Journal:  Protein Pept Lett       Date:  2008       Impact factor: 1.890

Review 9.  Exploring the accessible conformations of N-terminal acetylated α-synuclein.

Authors:  Gina M Moriarty; Maria K Janowska; Lijuan Kang; Jean Baum
Journal:  FEBS Lett       Date:  2013-03-13       Impact factor: 4.124

10.  Guiding protein aggregation with macromolecular crowding.

Authors:  Larissa A Munishkina; Atta Ahmad; Anthony L Fink; Vladimir N Uversky
Journal:  Biochemistry       Date:  2008-07-30       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.